• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳酸对伴有或不伴有弥散性血管内凝血的脓毒症患者死亡率预测的差异影响:一项多中心、回顾性、观察性研究

Differential effect of lactate in predicting mortality in septic patients with or without disseminated intravascular coagulation: a multicenter, retrospective, observational study.

作者信息

Hasegawa Daisuke, Nishida Kazuki, Hara Yoshitaka, Kawaji Takahiro, Moriyama Kazuhiro, Shimomura Yasuyo, Niimi Daisuke, Komura Hidefumi, Nishida Osamu

机构信息

1Department of Anesthesiology and Critical Care Medicine, School of Medicine, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192 Japan.

2Department of Biostatistics, Graduate School of Medicine, Nagoya University, Nagoya, Aichi Japan.

出版信息

J Intensive Care. 2019 Jun 24;7:2. doi: 10.1186/s40560-019-0389-x. eCollection 2019.

DOI:10.1186/s40560-019-0389-x
PMID:31293786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6591993/
Abstract

BACKGROUND

We examined whether high lactate level in septic patients was associated with 90-day mortality based on the patients' disseminated intravascular coagulation (DIC) status.

METHODS

We conducted a multicenter, retrospective, observational study of patients admitted to the intensive care unit (ICU) with a suspicion of severe infection and diagnosed with sepsis. Regression analyses were performed to estimate the interaction effect between DIC status and the lactate level. Then, the association between the lactate level and 90-day mortality was assessed in the DIC and non-DIC subgroups.

RESULTS

The data of 415 patients were analyzed. We found a significant interaction between DIC status and the lactate level for predicting 90-day mortality (  = 0.04). Therefore, we performed a subgroup analysis and found that high lactate concentration was significantly associated with 90-day mortality in the DIC group (odds ratio = 2.31,  = 0.039) but not in the non-DIC group.

CONCLUSIONS

In patients with DIC, a high lactate level significantly predicted 90-day mortality; no such association was found in the non-DIC group. Thus, DIC status may serve as a possible effect modifier of lactate level in predicting mortality in patients with sepsis.

摘要

背景

我们基于脓毒症患者的弥散性血管内凝血(DIC)状态,研究了高乳酸水平是否与90天死亡率相关。

方法

我们对入住重症监护病房(ICU)、疑似严重感染并被诊断为脓毒症的患者进行了一项多中心、回顾性观察研究。进行回归分析以估计DIC状态与乳酸水平之间的交互作用。然后,在DIC和非DIC亚组中评估乳酸水平与90天死亡率之间的关联。

结果

分析了415例患者的数据。我们发现DIC状态与乳酸水平之间在预测90天死亡率方面存在显著交互作用(P = 0.04)。因此,我们进行了亚组分析,发现高乳酸浓度在DIC组中与90天死亡率显著相关(比值比 = 2.31,P = 0.039),而在非DIC组中则不然。

结论

在DIC患者中,高乳酸水平显著预测90天死亡率;在非DIC组中未发现这种关联。因此,DIC状态可能是预测脓毒症患者死亡率时乳酸水平的一个可能的效应修饰因素。

相似文献

1
Differential effect of lactate in predicting mortality in septic patients with or without disseminated intravascular coagulation: a multicenter, retrospective, observational study.乳酸对伴有或不伴有弥散性血管内凝血的脓毒症患者死亡率预测的差异影响:一项多中心、回顾性、观察性研究
J Intensive Care. 2019 Jun 24;7:2. doi: 10.1186/s40560-019-0389-x. eCollection 2019.
2
Epidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systems.脓毒症中弥散性血管内凝血的流行病学及评分系统的验证。
J Crit Care. 2019 Apr;50:23-30. doi: 10.1016/j.jcrc.2018.11.009. Epub 2018 Nov 14.
3
The effect of recombinant human soluble thrombomodulin on renal function and mortality in septic disseminated intravascular coagulation patients with acute kidney injury: a retrospective study.重组人可溶性血栓调节蛋白对伴有急性肾损伤的脓毒症弥散性血管内凝血患者肾功能及死亡率的影响:一项回顾性研究
J Intensive Care. 2020 Dec 11;8(1):94. doi: 10.1186/s40560-020-00512-w.
4
Performance Evaluation of Five Different Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Predicting Mortality in Patients with Complicated Sepsis.五种不同的弥散性血管内凝血(DIC)诊断标准对复杂脓毒症患者死亡率预测的性能评估
J Korean Med Sci. 2016 Nov;31(11):1838-1845. doi: 10.3346/jkms.2016.31.11.1838.
5
Role of disseminated intravascular coagulation in severe sepsis.弥散性血管内凝血在严重脓毒症中的作用。
Thromb Res. 2019 Jun;178:182-188. doi: 10.1016/j.thromres.2019.04.025. Epub 2019 Apr 26.
6
Screening itself for disseminated intravascular coagulation may reduce mortality in sepsis: A nationwide multicenter registry in Japan.筛查弥散性血管内凝血本身可能降低脓毒症患者的死亡率:日本全国多中心登记研究。
Thromb Res. 2018 Jan;161:60-66. doi: 10.1016/j.thromres.2017.11.023. Epub 2017 Nov 26.
7
Antithrombin Supplementation and Mortality in Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study.抗凝血酶补充治疗与脓毒症诱发的弥散性血管内凝血患者死亡率:一项多中心回顾性观察研究
Shock. 2016 Dec;46(6):623-631. doi: 10.1097/SHK.0000000000000727.
8
Day 3 versus Day 1 disseminated intravascular coagulation score among sepsis patients: a prospective observational study.脓毒症患者第3天与第1天的弥散性血管内凝血评分:一项前瞻性观察研究。
Anaesth Intensive Care. 2016 Jan;44(1):57-64. doi: 10.1177/0310057X1604400110.
9
Early changes in coagulation profiles and lactate levels in patients with septic shock undergoing extracorporeal membrane oxygenation.接受体外膜肺氧合治疗的感染性休克患者凝血指标和乳酸水平的早期变化
J Thorac Dis. 2018 Mar;10(3):1418-1430. doi: 10.21037/jtd.2018.02.28.
10
Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.重组人可溶性血栓调节蛋白与脓毒症诱发的弥散性血管内凝血的死亡率。一项多中心回顾性研究。
Thromb Haemost. 2016 Jun 2;115(6):1157-66. doi: 10.1160/TH15-12-0987. Epub 2016 Mar 3.

引用本文的文献

1
Granulocyte and Monocyte Adsorption Therapy in Patients With Sepsis: A Feasibility Study.脓毒症患者的粒细胞和单核细胞吸附疗法:一项可行性研究。
Artif Organs. 2025 May;49(5):852-863. doi: 10.1111/aor.14943. Epub 2025 Jan 17.
2
Investigation of the Possible Causes of NRBC in ICU Patients and the Dynamic Trend of NRBC Count in Survival and Death Patients or with Different Underlying Diseases: A Retrospective Study.ICU患者中性中幼粒细胞出现的可能原因及生存与死亡患者或不同基础疾病患者中性中幼粒细胞计数的动态趋势研究:一项回顾性研究
Evid Based Complement Alternat Med. 2023 Jan 14;2023:9076647. doi: 10.1155/2023/9076647. eCollection 2023.
3

本文引用的文献

1
Sepsis and septic shock.脓毒症和脓毒性休克。
Lancet. 2018 Jul 7;392(10141):75-87. doi: 10.1016/S0140-6736(18)30696-2. Epub 2018 Jun 21.
2
Differential effect of mild therapeutic hypothermia depending on the findings of hypoxic encephalopathy on early CT images in patients with post-cardiac arrest syndrome.心肺复苏后综合征患者早期 CT 图像缺氧性脑病表现对亚低温治疗效果的影响。
Resuscitation. 2018 Jul;128:11-15. doi: 10.1016/j.resuscitation.2018.04.029. Epub 2018 Apr 23.
3
Enhancing Recovery From Sepsis: A Review.脓毒症康复的促进:综述
Association between hypomagnesemia and coagulopathy in sepsis: a retrospective observational study.
低镁血症与脓毒症凝血障碍的关系:一项回顾性观察研究。
BMC Anesthesiol. 2022 Nov 24;22(1):359. doi: 10.1186/s12871-022-01903-2.
4
Admission serum lactate is associated with all-cause mortality in the pediatric intensive care unit.入院时血清乳酸水平与儿科重症监护病房的全因死亡率相关。
Am J Transl Res. 2022 Jun 15;14(6):4124-4131. eCollection 2022.
5
Effects of Thrombomodulin in Reducing Lethality and Suppressing Neutrophil Extracellular Trap Formation in the Lungs and Liver in a Lipopolysaccharide-Induced Murine Septic Shock Model.血栓调节蛋白对脂多糖诱导的脓毒性休克模型肺和肝组织中中性粒细胞胞外诱捕网形成及致死率的影响。
Int J Mol Sci. 2021 May 6;22(9):4933. doi: 10.3390/ijms22094933.
6
Anticoagulant therapy for septic coagulopathy and disseminated intravascular coagulation: where do KyberSept and SCARLET leave us?脓毒症性凝血病和弥散性血管内凝血的抗凝治疗:KyberSept和SCARLET研究将我们置于何处?
Acute Med Surg. 2020 Jan 16;7(1):e477. doi: 10.1002/ams2.477. eCollection 2020 Jan-Dec.
JAMA. 2018 Jan 2;319(1):62-75. doi: 10.1001/jama.2017.17687.
4
Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice.在小鼠脓毒症期间,血小板与中性粒细胞胞外诱捕网协同作用促进血管内凝血。
Blood. 2017 Mar 9;129(10):1357-1367. doi: 10.1182/blood-2016-09-741298. Epub 2017 Jan 10.
5
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).《脓毒症及脓毒性休克第三次国际共识定义(脓毒症-3)》
JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.
6
Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).脓毒症临床标准评估:针对《脓毒症及脓毒性休克第三次国际共识定义》(Sepsis-3)。
JAMA. 2016 Feb 23;315(8):762-74. doi: 10.1001/jama.2016.0288.
7
PAMPs and DAMPs as triggers for DIC.PAMPs 和 DAMPs 作为 DIC 的触发因素。
J Intensive Care. 2014 Dec 31;2(1):67. doi: 10.1186/s40560-014-0065-0. eCollection 2014.
8
Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study.拯救脓毒症运动:一项长达 7.5 年的研究中,绩效指标与结局之间的关系。
Intensive Care Med. 2014 Nov;40(11):1623-33. doi: 10.1007/s00134-014-3496-0. Epub 2014 Oct 1.
9
A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation.一项随机、双盲、安慰剂对照、2b 期研究,旨在评估重组人可溶性血栓调节蛋白(ART-123)在脓毒症和疑似弥漫性血管内凝血患者中的安全性和疗效。
Crit Care Med. 2013 Sep;41(9):2069-79. doi: 10.1097/CCM.0b013e31828e9b03.
10
A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis.日本急性医学协会弥散性血管内凝血评分系统在严重脓毒症患者中的多中心前瞻性验证研究。
Crit Care. 2013 Jun 20;17(3):R111. doi: 10.1186/cc12783.